| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
355,150,000 |
| Market
Cap: |
2.50(B) |
| Last
Volume: |
17,273,575 |
Avg
Vol: |
17,225,593 |
| 52
Week Range: |
$5.72 - $10.61 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
6,313 |
6,533 |
13,261 |
14,828 |
| Total Sell Value |
$61,867 |
$63,491 |
$119,170 |
$133,715 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
1 |
2 |
4 |
7 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Icahn Brett |
Director |
• • – |
2021-03-31 |
4 |
A |
$31.74 |
$3,999 |
D/D |
126 |
870 |
|
- |
|
| Miller Steven D |
Director |
• • – |
2021-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
744 |
844 |
|
- |
|
| Icahn Brett |
Director |
• • – |
2021-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
744 |
744 |
|
- |
|
| Miller Steven D |
Director |
– • – |
2021-03-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100 |
|
-16% |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2021-03-11 |
4 |
D |
$32.82 |
$26,125 |
D/D |
(796) |
166,758 |
|
- |
|
| Papa Joseph C |
CHAIRMAN & CEO |
• • – |
2021-03-10 |
4 |
D |
$32.97 |
$7,622,268 |
D/D |
(231,188) |
1,039,978 |
|
- |
|
| Eldessouky Sam |
SVP, CHIEF ACCOUNTING OFFICER |
• • – |
2021-03-10 |
4 |
D |
$32.97 |
$242,692 |
D/D |
(7,361) |
100,184 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2021-03-10 |
4 |
D |
$32.97 |
$724,021 |
D/D |
(21,960) |
167,554 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2021-03-10 |
4 |
D |
$32.97 |
$576,316 |
D/D |
(17,480) |
230,426 |
|
- |
|
| Herendeen Paul |
EVP and CFO |
• • – |
2021-03-10 |
4 |
D |
$32.97 |
$1,962,341 |
D/D |
(59,519) |
386,618 |
|
- |
|
| Gordon Joseph F |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2021-03-10 |
4 |
D |
$32.97 |
$410,839 |
D/D |
(12,461) |
110,638 |
|
- |
|
| Papa Joseph C |
CHAIRMAN & CEO |
• • – |
2021-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
108,254 |
1,271,166 |
|
- |
|
| Papa Joseph C |
CHAIRMAN & CEO |
• • – |
2021-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
317,089 |
1,162,912 |
|
- |
|
| Eldessouky Sam |
SVP, CHIEF ACCOUNTING OFFICER |
• • – |
2021-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
13,530 |
107,545 |
|
- |
|
| Eldessouky Sam |
SVP, CHIEF ACCOUNTING OFFICER |
• • – |
2021-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,404 |
94,015 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2021-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
25,980 |
189,514 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2021-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,455 |
163,534 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2021-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
28,144 |
247,906 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2021-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,161 |
219,762 |
|
- |
|
| Herendeen Paul |
EVP and CFO |
• • – |
2021-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
50,518 |
446,137 |
|
- |
|
| Herendeen Paul |
EVP and CFO |
• • – |
2021-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
49,324 |
395,619 |
|
- |
|
| Gordon Joseph F |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2021-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
17,320 |
123,099 |
|
- |
|
| Gordon Joseph F |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2021-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,637 |
105,779 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
32,626 |
210,601 |
|
- |
|
| Spurr Robert |
President, Salix |
• • – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
23,892 |
59,336 |
|
- |
|
1049 Records found
|
|
Page 9 of 42 |
|
|
0.38 (5.13%) 
